home / stock / cyto / cyto quote
Last: | $1.44 |
---|---|
Change Percent: | -1.27% |
Open: | $1.6 |
Close: | $1.44 |
High: | $1.6 |
Low: | $1.4 |
Volume: | 2,975,883 |
Last Trade Date Time: | 04/24/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.44 | $1.6 | $1.44 | $1.6 | $1.4 | 2,975,883 | 04-24-2024 |
$1.58 | $1.4 | $1.58 | $1.58 | $1.38 | 109,688 | 04-23-2024 |
$1.4 | $1.39 | $1.4 | $1.52 | $1.38 | 107,242 | 04-22-2024 |
$1.414 | $1.5 | $1.414 | $1.5 | $1.405 | 46,743 | 04-19-2024 |
$1.5 | $1.46 | $1.5 | $1.5185 | $1.42 | 24,812 | 04-18-2024 |
$1.48 | $1.65 | $1.48 | $1.65 | $1.48 | 90,008 | 04-17-2024 |
$1.63 | $1.65 | $1.63 | $1.73 | $1.54 | 56,575 | 04-16-2024 |
$1.66 | $1.8 | $1.66 | $1.88 | $1.65 | 120,702 | 04-15-2024 |
$1.83 | $1.89 | $1.83 | $1.95 | $1.81 | 41,161 | 04-12-2024 |
$1.82 | $1.94 | $1.82 | $1.99 | $1.8 | 171,833 | 04-11-2024 |
$2 | $1.87 | $2 | $2.01 | $1.87 | 176,244 | 04-10-2024 |
$1.86 | $1.92 | $1.86 | $2.0299 | $1.86 | 121,135 | 04-09-2024 |
$1.92 | $2.01 | $1.92 | $2.06 | $1.9 | 172,969 | 04-08-2024 |
$1.95 | $2.09 | $1.95 | $2.09 | $1.86 | 80,126 | 04-05-2024 |
$2.09 | $1.98 | $2.09 | $2.09 | $1.9285 | 94,021 | 04-04-2024 |
$1.94 | $2 | $1.94 | $2.0185 | $1.77 | 169,874 | 04-03-2024 |
$2.05 | $2.02 | $2.05 | $2.09 | $1.77 | 113,042 | 04-02-2024 |
$2.11 | $2.05 | $2.11 | $2.1344 | $1.99 | 114,749 | 04-01-2024 |
$2.07 | $2.41 | $2.07 | $2.49 | $1.96 | 334,107 | 03-29-2024 |
$2.07 | $2.41 | $2.07 | $2.49 | $1.96 | 334,107 | 03-28-2024 |
News, Short Squeeze, Breakout and More Instantly...
Altamira Therapeutics Ltd. Company Name:
CYTO Stock Symbol:
NASDAQ Market:
Hamilton, Bermuda, April 24, 2024 (GLOBE NEWSWIRE) -- Detailed results from randomized controlled Bentrio® trial in seasonal allergic rhinitis published in Allergy journal Study met primary efficacy endpoint of improvement in nasal symptoms (p = 0.013) Corroborated ...
Hamilton, Bermuda, April 10, 2024 (GLOBE NEWSWIRE) -- Management to host conference call today, April 10, at 8.30 a.m. EDT RNA delivery business progressing with new collaborations, potential new applications Partnering of legacy assets underway as Company transitions to f...
Hamilton, Bermuda, April 04, 2024 (GLOBE NEWSWIRE) -- Altamira Therapeutics Ltd. ("Altamira" or the "Company") (Nasdaq: CYTO), a company providing nanoparticle-based technology for efficient RNA delivery to extrahepatic targets, today announced that it will host its Full Year 2023 Financial Resul...